This Blue-Chip Stock Is a Heavy Weight in Weight-Loss Drugs

Eli Lilly (LLY) stands out for its diversified pharmaceutical portfolio, robust pipeline, and strategic acquisitions that are fueling growth. LLY has strong technical momentum and is trading at new all-time highs. Shares are up 43% over the past year. Analyst sentiment is overwhelmingly positive, with most major firms rating LLY a “Buy.” Today’s Featured Stock Valued at $973.8 billion, Eli Lilly (LLY) is one of the world’s largest pharmaceutical companies. It boasts a diversified product profile ...